[1] |
Bleul CC, Fuhlbrigge RC, Casasnovas JM, et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J]. J Exp Med,1996,184(3):1101-1109.
|
[2] |
Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J]. J Biol Chem,2005,280(42):35760-35766.
|
[3] |
Sun X, Cheng G, Hao M, et al. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression [J]. Cancer Metastasis Rev,2010,29(4):709-722.
|
[4] |
Teicher BA,Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer [J]. Clin Cancer Res, 2010,16(11):2927-2931.
|
[5] |
Vlahakis SR, Villasis-Keever A, Gomez T, et al. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways [J]. J Immunol,2002,169(10):5546-5554.
|
[6] |
Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4 [J]. Cancer Res,2002,62(24):7203-7206.
|
[7] |
Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis [J]. Nature,2001,410(6824):50-56.
|
[8] |
Hassan S, Baccarelli A, Salvucci O, et al. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer [J]. Clin Cancer Res, 2008, 14(2): 446-454.
|
[9] |
Zhou W, Jiang Z, Song X, et al. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma[J]. J Neurosci Res,2008,86(13):3002-3010.
|
[10] |
Sowin′ ska A, Jagodzinski PP. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines [J]. Cancer Lett,2007,255(1):153-159.
|
[11] |
Wendt MK, Johanesen PA, Kang-Decker N, et al. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis [J].
|
[12] |
Pietkiewicz PP, Lutkowska A, Lianeri M, et al. Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast[J]. Biomed Pharmacother,2010,64(1):54-57.
|
[13] |
Chen L, Xu SG, Zeng XH, et al. c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells cancer cells [J]. Acta Biochim Biophys Sin,2010,42(1):1-7.
|
[14] |
Xin JH, Cowie A, Lachance P, et al. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells [J]. Genes Dev,1992,6(3):481-496.
|
[15] |
Monte D, Coutte L, Baert JL, et al. Molecular characterization of the Ets-related human transcription factor ER81 [J].Oncogene,1995,11(4):771-779.
|
[16] |
Monte D, Baert JL, Defossez PA, et al. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. [J]. Oncogene, 1994,9(5):1397-1406.
|
[17] |
Clementz AG, Rogowski AS, Pandya K, et al. Notch-1 and Notch-4 are novel gene targets of pea3 in breast cancer: novel therapeutic implications[J]. Breast Cancer Res, 2011,13(3):R63.
|
[18] |
Shepherd TG, Kockeritz L, Szrajber MR, et al. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis [J]. Curr Biol,2001,11(22):1739-1748.
|
[19] |
Hua D, Chen B, Bai M, et al. PEA3 activates VEGF transcription in T47D and SKBR3 breast cancer cells [J]. Acta Biochim Biophys Sin, 2009,41(1):63-68.
|
[20] |
Ni J, Kalff-Suske M, Gentz R, et al. All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster [J]. Ann NY Acad Sci,2000,12(923):25-42.
|
[21] |
Chen Y, Chen L, Li JY, et al. ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells[J]. Cancer Biol Ther, 2011,11(5):497-511.
|
[22] |
Baker R, Kent CV, Silbermann RA, et al. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia [J].PLoS One, 2010,5(1):e8854.
|
[23] |
Qin L, Liu Z, Chen H, et al. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis [J]. Cancer Res, 2009,69(9):3819-3827.
|
[24] |
Su Z, Shi Y, Friedman R, et al. PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogenactivated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells [J]. Nucleic Acids Res,2001,29(8):1661-1671.
|
[25] |
Su ZZ, Shi YJ, Fisher PB. Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3)promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells [J]. Oncogene,2000,19(30):3411-3421.
|